pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,472 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT954Endpoints730BioPharma Dive280BioSpace177Fierce Biotech167onclive165globenewswire health73raps59
therapy area
allOncology5565Rare Disease1215Cardiology1039Hematology916Immunology907Vaccines792Pulmonology
  • The risk of refusing a newborn’s vitamin K shot
    Health care workers on strike at Ebola treatment center, how to tackle the U.S. alcohol epidemic, and more Morning Rounds news
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and more
    A U.S. appeals court revived a Teva Pharmaceuticals lawsuit accusing Eli Lilly of breaching ​an agreement allowing Teva to market a generic ‌version of Forteo
    STAT · 1mo ago↗ source
  • STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
    An experimental Alzheimer's drug from Biogen, one with a novel approach, slowed decline at comparable rates as approved drugs in a mid-stage study.
    STAT
← prev
page 20 of 59
next →
fda recalls39
fda medwatch29
fda press25
768
Psychiatry & CNS677
Ophthalmology338
Endocrinology & Metabolism335
Pain328
Infectious Disease320
· 1mo ago
↗ source
  • Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
    The study provides the clearest evidence yet that medicines like BIIB080 might improve cognition, but leaves unclear why higher doses didn’t perform better.
    BioPharma Dive · 1mo ago↗ source
  • FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist
    A former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing their safety
    STAT · 1mo ago↗ source
  • Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctor
    Deepfakes undermine the credibility that makes digital care — from telehealth visits to patient portals — possible.
    STAT · 1mo ago↗ source
  • STAT+: 10 charts that explain America’s hidden alcohol epidemic
    America's hidden alcohol epidemic — the toll, emerging risks, shifting usage, and economic stakes — broken down in 10 charts.
    STAT · 1mo ago↗ source
  • 12 ideas for tackling the U.S. alcohol epidemic
    The U.S. can save lives from excess alcohol use without taking drastic measures. Here are 12 steps that can help.
    STAT · 1mo ago↗ source
  • STAT+: Drug metabolism AI competition results show that bigger may not always be better
    The results of a recent AI competition show that better data trumps bigger models when it comes to predicting properties of drug candidates.
    STAT · 1mo ago↗ source
  • STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
    A group of AIDS activists obtained an R&D pact at the heart of a settlement between the U.S. government and Gilead Sciences over patents for HIV prevention.
    STAT · 1mo ago↗ source
  • Freenome colorectal cancer test data improve on earlier results
    The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Dementia study replicates promising outcomes following risk-reduction strategies
    A dementia prevention trial praised as a "landmark" effort further demonstrated the promise of structured programs tailored to local cultures.
    STAT · 1mo ago↗ source
  • Q32 bounces back to claim study success for alopecia drug
    Nearly two years after clinical setbacks cratered Q32’s stock price, new results showed hair growth improvements that surpassed investors’ expectations.
    BioPharma Dive · 1mo ago↗ source
  • Agenus surges on study pivot; Apnimed lines up an IPO
    Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: UnitedHealth’s questionable review, and more MA stars lawsuits
    UnitedHealth touts a new home care audit, and more health insurers sue CMS over Medicare Advantage quality ratings.
    STAT · 1mo ago↗ source
  • Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma
    Martha Lillard, last U.S. polio patient using iron lung, has died at 78 in Oklahoma.
    STAT · 1mo ago↗ source
  • STAT+: All eyes on data on Biogen’s tau therapy
    The year of daraxonrasib, a wearable for a myeloma drug, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and more
    U.S. health secretary Robert F. Kennedy Jr. is pressing forward with his effort to help Americans stop taking SSRI antidepressants
    STAT · 1mo ago↗ source
  • Caregivers brace for pay cuts, and maybe homelessness
    A game-changer in pancreatic cancer, a vaccine skeptical HHS nom, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • Biotech startup funding gap widens despite rebound in VC investment
    Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that small startups are being left behind.
    BioPharma Dive · 1mo ago↗ source
  • Opinion: The shortage of forensic pathologists is hurting justice, public health, and families
    It’s time to solve the case of the missing pathologist.
    STAT · 1mo ago↗ source
  • Opinion: Is there a doctor on board? Yes, and airlines depend on it
    Physicians who volunteer on flights assume responsibility with no patient history, limited equipment, and an audience of 200 people.
    STAT · 1mo ago↗ source
  • STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to come
    Pancreatic cancer specialists are excited about the biggest breakthrough in the field in decades. They are also looking around the corner to what comes next.
    STAT · 1mo ago↗ source
  • As states absorb Medicaid funding cuts, family caregivers face financial ruin
    Family caregivers of people with disabilities face a grim financial future as several states consider steep cuts to their wages.
    STAT · 1mo ago↗ source
  • STAT+: HHS presses ahead with effort to curb antidepressant use
    In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.
    STAT · 1mo ago↗ source